Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 203 entries
View as:

Study to Evaluate NA-NOSE for Monitoring and Detecting Recurrence in Early Stage Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01840150 Org: User:
Start: 08/23/12 End: 07/05/19 Due: 07/05/20

Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)

Phase: N/A Priority: Normal
NCT ID: NCT06396533 Org: User:
Start: 08/13/24 End: 02/23/29 Due: 02/23/30

Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00062296 Org: User:
Start: 03/31/03 End: 08/31/05 Due: 08/31/06

A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT02147080 Org: User:
Start: 03/31/11 End: 10/31/14 Due: 10/31/15

Computed Tomography in Detecting Movement of the Esophagus in Patients Undergoing Radiation Therapy to the Chest

Phase: N/A Priority: Normal
NCT ID: NCT00433524 Org: User:
Start: 04/30/03 End: 09/30/07 Due: 09/30/08

Testing Gene PilotLX With Latinx Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06476938 Org: User:
Start: 05/01/25 End: 12/31/27 Due: 12/31/28

Pulse-low-dose Rate (PLDR) Radiation in Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04452357 Org: User:
Start: 01/13/20 End: 12/01/25 Due: 12/01/26

Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT01059552 Org: User:
Start: 12/16/09 End: 10/21/19 Due: 10/21/20

Perioperative Risk Study

Phase: N/A Priority: Normal
NCT ID: NCT02456389 Org: User:
Start: 08/31/14 End: 06/30/25 Due: 06/30/26

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05800587 Org: User:
Start: 02/22/23 End: 08/01/29 Due: 08/01/30

Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder

Phase: N/A Priority: Normal
NCT ID: NCT02968732 Org: User:
Start: 11/11/16 End: 04/01/27 Due: 04/01/28

Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening

Phase: N/A Priority: Normal
NCT ID: NCT04557423 Org: User:
Start: 04/08/21 End: 11/30/25 Due: 11/30/26

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06984562 Org: User:
Start: 08/01/25 End: 08/01/29 Due: 08/01/30

Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01169532 Org: User:
Start: 10/31/10 End: 03/31/14 Due: 03/31/15

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00021320 Org: User:
Start: 05/31/00 End: 04/30/09 Due: 04/30/10

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01280643 Org: User:
Start: 03/31/10 End: 05/31/14 Due: 05/31/15

Safety and Activity of Digoxin With Decitabine in Adult AML and MDS

Phase: N/A Priority: Normal
NCT ID: NCT03113071 Org: User:
Start: 06/02/17 End: 03/11/19 Due: 03/11/20

Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02963610 Org: User:
Start: 03/29/17 End: 03/20/18 Due: 03/20/19

Impact of Ribociclib on Head and Neck Squamous Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03179956 Org: User:
Start: 04/02/18 End: 01/10/19 Due: 01/10/20

A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02616965 Org: User:
Start: 02/22/17 End: 01/31/24 Due: 01/31/25

Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03099499 Org: User:
Start: 06/08/17 End: 09/09/20 Due: 09/09/21

Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00315185 Org: User:
Start: 12/31/04 End: 06/30/08 Due: 06/30/09

HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04668768 Org: User:
Start: 04/16/21 End: 04/30/25 Due: 04/30/26

Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02050009 Org: User:
Start: - End: 10/31/14 Due: 10/31/15

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04379999 Org: User:
Start: 09/10/18 End: 12/31/25 Due: 12/31/26